Polypharmacy in the Nursing Home

Journal of the American Medical Directors Association

Volumn 10, Issue 5, 2009, Pages 289-291

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DOCUSATE SODIUM; FISH OIL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; LAXATIVE; LEVOTHYROXINE; LUBIPROSTONE; METFORMIN; NEUROLEPTIC AGENT; PLACEBO; PROTON PUMP INHIBITOR; TESTOSTERONE; UNINDEXED DRUG; VITAMIN D; WARFARIN;

BEHAVIOR DISORDER; BEHAVIOR THERAPY; CALCIUM DEPLETION; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CONSTIPATION; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDICATION; DRUG PREFERENCE; DRUG USE; EDITORIAL; EXERCISE; FRAIL ELDERLY; GERIATRIC CARE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HIP FRACTURE; HUMAN; HYPERTENSION; INCONTINENCE; LONG TERM CARE; NURSING HOME; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY OF LIFE; SIDE EFFECT; TOTAL QUALITY MANAGEMENT; UNSPECIFIED SIDE EFFECT;

EID: 66049137771     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2009.03.011     Document Type: Editorial

References (45)

1. Abelland van Kan G., Rolland Y.M., Morley J.E., and Vellas B. Frailty: Toward a clinical definition. J Am Med Dir Assoc 9 (2008) 71-72
2. Abellan van Kan G., Rolland Y., Bergman H., et al. The IANA Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 12 (2008) 29-37
3. Morley J.E., Perry III H.M., and Miller D.K. Editorial: Something about frailty. J Gerontol A Biol Sci Med Sci 57 (2002) M698-M704
4. Rockwood K., Abeysundera M.J., and Mitnitski A. How should we grade frailty in nursing home patients?. J Am Med Dir Assoc 8 (2007) 595-603
5. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 163 (2003) 2716-2724
6. Morley J.E. Phronesis and the medical director. J Am Med Dir Assoc 10 (2009) 149-152
7. Reimersma-van der Lek R.F., Swaab D.F., Twisk J., et al. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: A randomized controlled trial. JAMA 299 (2008) 2642-2655
8. De Lepeleire J., Bouwen A., De Coninck L., and Buntinx F. Insufficient lighting in nursing homes. J Am Med Dir Assoc 8 (2007) 314-317
9. Fox T., and Jacobs M. The magic of exercise. J Am Med Dir Assoc 9 (2008) 375-377
10. Colberg S.R., Somma C.T., and Sechrist S.R. Physical activity participation may offset some of the negative effects of diabetes on cognitive function. J Am Med Dir Assoc 9 (2008) 434-438
11. Rolland Y., Abellan van Kan G., and Vellas B. Physical activity and Alzheimer's disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 9 (2008) 390-405
12. Morley J.E. The magic of exercise. J Am Med Dir Assoc 9 (2008) 375-377
13. Morley J.E. Managing persons with dementia in the nursing home: High touch trumps high tech. J Am Med Dir Assoc 9 (2008) 139-146
14. Hui E.K., and Rubenstein L.Z. Promoting physical activity and exercise in older adults. J Am Med Dir Assoc 7 (2006) 310-314
15. Raina P., Santaguida P., Ismaila A., et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann Intern Med 148 (2008) 379-397
16. Tariq S.H., Tumosa N., Chibnall J.T., et al. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder-a pilot study. Am J Geriatr Psychiatry 14 (2006) 900-910
17. Ray W.A., Chung C.P., Murray K.T., et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360 (2009) 225-235
18. Schneider L.S., Tariot P.N., Dagerman K.S., et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 355 (2006) 1525-1538
19. Levenson S.A., and Morley J.E. Evidence rocks in long-term care, but does it roll?. J Am Med Dir Assoc 8 (2007) 493-501
20. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
21. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
22. Joseph J., Koka M., and Aronow W.S. Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home. J Am Med Dir Assoc 9 (2008) 51-54
23. Skyler J.S., Bergenstal R., Bonow R.O., et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Associaton and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 53 (2009) 298-304
24. Kim M.J., Rolland Y., Cepeda O., et al. Diabetes mellitus in older men. Aging Male 9 (2006) 139-147
25. Mazza A.D., and Morley J.E. Update on diabetes in the elderly and the application of current therapeutics. J Am Med Dir Assoc 8 (2007) 489-492
26. Buckingham R.E., and Hanna A. Thiazolidinedione insulin sensitizers and the heart: A tale of two organs?. Diabetes Obes Metab 10 (2008) 312-328
27. Schwartz A.V. TZDs and bone: A review of the recent clinical evidence. PPAR Res 2008 (2008) 297893
28. Bolland M.J., Barber P.A., Doughty R.N., et al. Vascular events in healthy older women receiving calcium supplementation: Randomized controlled trial. BMJ 336 (2008) 262-266
29. Tariq S.H. Constipation in long-term care. J Am Med Dir Assoc 8 (2007) 209-218
30. Bhutto A., and Morley J.E. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care 11 (2008) 651-660
31. Lawhorne L.W., Ouslander J.G., and Parmelee P.A. Urinary Incontinence Work Group of the AMDA-F LTC Research Network. Clinical practice guidelines, process improvement teams, and performance on a quality indicator for urinary incontinence: A pilot study. J Am Med Dir Assoc 9 (2008) 504-508
32. Al-Samarrai N.R., Uman G.C., Al-Samarrai T., and Alessi C.A. Introducing a new incontinence management system for nursing home residents. J Am Med Dir Assoc 8 (2007) 253-261
33. Messinger-Rapport B.J., Thomas D.R., Gammack J.K., and Morley J.E. Clinical update on nursing home medicine: 2008. J Am Med Dir Assoc 9 (2008) 460-475
34. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 360 (2002) 1623-1630
35. Gissi-HF I., Tavazzi L., Maggioni A.P., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 372 (2008) 1223-1230
36. Joseph J., Koka M., and Aronow W.S. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiontensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. J Am Med Dir Assoc 9 (2008) 124-127
37. Abdel-Latif A.K., Peng X., and Messinger-Rapport B.J. Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation. J Am Med Dir Assoc 6 (2005) 128-131
38. Morley J.E. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des 13 (2007) 3637-3647
39. Morley J.E., and Thomas D.R. Cachexia: new advances in the management of wasting diseases. J Am Med Dir Assoc 9 (2008) 205-210
40. Morley J.E., Haren M.T., Rolland Y., and Kim M.J. Frailty. Med Clin North Am 90 (2006) 837-847
41. Messinger-Rapport B.J., Morley J.E., Thomas D.R., and Gammack J.K. Intensive session: New approaches to medical issues in long-term care. J Am Med Dir Assoc 8 (2007) 421-433
42. Locca J.F., Bula C.J., Zumbach S., and Bugnon O. Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: Development of practice recommendations in a Swiss canton. J Am Med Dir Assoc 9 (2008) 439-448
43. Thakur M., and Blazer D.G. Depression in long-term care. J Am Med Dir Assoc 9 (2008) 82-87
44. Harrington B.C., Dickey L., and Heiner S. Our experience with proton pump inhibitor (PPI) use in our local long-term care facility. J Am Med Dir Assoc 9 (2008) 280-281
45. Glew C.M., and Rantler R.J. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. J Am Med Dir Assoc 9 (2008) 280-281